ACQUIRED · 2024
Who Acquired Ulster Dialysis?
U.S. Renal Care · $2.3M· 5.8× EBITDA
The acquisition
Ulster Dialysis was acquired by U.S. Renal Care in 2024 for $2.3M. The deal was priced at 5.8× EBITDA / 0.50× revenue.
Ulster Dialysis at time of acquisition
Revenue
$4.6M
EBITDA
$0.4M
Deal value
$2.3M
EV / EBITDA
5.8×
Similar medical practice specialty acquisitions
- Consulting Cardiologists · acquired by Hartford HealthCare in 2026 · $3.0M
- EyeSouth Partners' Retina Business · acquired by Cencora, Inc. in 2026 · $1.10B
- OneOncology · acquired by Cencora, Inc. in 2025 · $7.40B
- OrthoAlliance · acquired by Optum / SCA Health in 2025 · $1.40B
- OrthoNY · acquired by Zenyth Partners / Evolve Orthopedic Partners in 2025 · $110.0M
Run a valuation for a similar medical practice specialty business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the medical practice specialty calculator →More on medical practice specialty valuations
- Medical Practice Specialty valuation calculator· head-term variant
- Medical Practice Specialty median multiples· real-deal benchmarks
- How to value a medical practice specialty· long-form guide
Sourced from CON filings. Full deal page.
Citation: ExitValue.ai. (2024). Ulster Dialysis acquired by U.S. Renal Care. https://exitvalue.ai/acquired/ulster-dialysis